Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$432M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$193M |
| 3 |
iShares MSCI South Korea ETF
EWY
|
+$95.9M |
| 4 |
Molson Coors Class B
TAP
|
+$28.7M |
| 5 |
iShares MSCI Brazil ETF
EWZ
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$172M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$47.9M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$21.1M |
| 4 |
Intel
INTC
|
+$20.4M |
| 5 |
JNPR
Juniper Networks
JNPR
|
+$18.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 2.75% |
| 2 | Technology | 2.62% |
| 3 | Consumer Discretionary | 2.44% |
| 4 | Financials | 1.98% |
| 5 | Healthcare | 1.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
McDonald's
MCD
$195B
| $2.8M | 0.03% |
23,030
-86,257
| -79% | -$10.1M |
|
177
Cintas
CTAS
$81.3B
| $2.77M | 0.03% |
96,020
+84,420
| +728% | +$2.37M |
|
|
CTRA
178
DELISTED
Coterra Energy
CTRA
| $2.75M | 0.03% |
117,780
-20,700
| -15% | -$465K |
|
179
Gold Fields
GFI
$36.5B
| $2.74M | 0.03% |
911,600
+202,400
| +29% | +$725K |
|
180
Eldorado Gold
EGO
$9.89B
| $2.66M | 0.03% |
164,900
+45,320
| +38% | +$712K |
|
181
Franklin Resources
BEN
$17.2B
| $2.62M | 0.02% |
66,300
+40,000
| +152% | +$1.5M |
|
182
W.W. Grainger
GWW
$60.2B
| $2.6M | 0.02% |
+11,200
| New | +$2.5M |
|
183
Consolidated Edison
ED
$39.8B
| $2.59M | 0.02% |
+35,100
| New | +$2.54M |
|
184
Cognizant
CTSH
$26B
| $2.58M | 0.02% |
+45,970
| New | +$2.46M |
|
185
International Flavors & Fragrances
IFF
$21.9B
| $2.48M | 0.02% |
+21,080
| New | +$2.64M |
|
186
Western Union
WU
$2.21B
| $2.39M | 0.02% |
109,947
-131,453
| -54% | -$2.73M |
|
187
American Tower
AMT
$80.4B
| $2.38M | 0.02% |
+22,485
| New | +$2.44M |
|
188
B2Gold
BTG
$6.7B
| $2.35M | 0.02% |
990,305
+117,805
| +14% | +$293K |
|
189
Zimmer Biomet
ZBH
$18.4B
| $2.25M | 0.02% |
+22,454
| New | +$2.41M |
|
190
Northern Trust
NTRS
$33.9B
| $2.24M | 0.02% |
25,200
-15,300
| -38% | -$1.22M |
|
191
Kilroy Realty
KRC
$4.42B
| $2.19M | 0.02% |
29,900
+23,400
| +360% | +$1.67M |
|
192
VF Corp
VFC
$5.89B
| $2.15M | 0.02% |
42,905
-253,437
| -86% | -$13.1M |
|
193
Range Resources
RRC
$8.95B
| $2.14M | 0.02% |
62,404
-13,400
| -18% | -$479K |
|
194
Ameriprise Financial
AMP
$48.8B
| $2.11M | 0.02% |
19,000
+8,100
| +74% | +$855K |
|
195
Stanley Black & Decker
SWK
$15.7B
| $2.05M | 0.02% |
+17,900
| New | +$2.13M |
|
196
Williams-Sonoma
WSM
$29.6B
| $2.05M | 0.02% |
+84,600
| New | +$2.16M |
|
197
SITE Centers
SITC
$165M
| $2.05M | 0.02% |
103,973
+73,783
| +244% | +$1.47M |
|
198
Kimco Realty
KIM
$16.4B
| $2.04M | 0.02% |
+81,200
| New | +$2.14M |
|
|
NGD
199
DELISTED
New Gold Inc
NGD
| $1.99M | 0.02% |
565,600
+128,200
| +29% | +$487K |
|
200
Boston Scientific
BSX
$71.5B
| $1.97M | 0.02% |
91,000
+40,100
| +79% | +$875K |
|
Similar funds
Ray Dalio's Q4 2016 Portfolio in Review
As of Q4 2016, Ray Dalio held 377 positions worth $10.5B, up 3.7% from $10.2B the previous quarter. Its ten largest holdings account for 83% of the portfolio.
Ray Dalio deployed $653M of net new capital in Q4 2016, opening 78 new positions and adding to 101 existing holdings. Its largest new stake was UnitedHealth: 163,900 shares worth $26.2M.
By sector, the portfolio is most concentrated in Energy at 2.8% of assets, down from 2.9% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $172M trimmed.
- Ray Dalio's largest Q4 2016 buy was UnitedHealth: 163,900 shares worth $26.2M.
- Ray Dalio added most to Vanguard FTSE Emerging Markets ETF in Q4 2016, an estimated $432M increase.
- Ray Dalio's biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $172M.
- Ray Dalio fully exited Bristol-Myers Squibb in Q4 2016, selling an estimated $21.1M.
- Ray Dalio's ten largest holdings make up 83% of its $10.5B portfolio in Q4 2016.
- Ray Dalio opened 78 new positions and closed 110 in Q4 2016.
- Ray Dalio's portfolio value rose 3.7% quarter-over-quarter to $10.5B.
Based on Bridgewater Associates's 13F filing for Q4 2016, filed 10 Feb 2017.